CW
Therapeutic Areas
Evolva Holding SA Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Resveratrol | Dietary Supplement (Cardiovascular/Metabolic Health) | Commercial |
| Veri-te™ Resveratrol | Premium Dietary Supplement Ingredient | Commercial |
| Nootkatone | Insect Repellent / Flavor & Fragrance | Commercial |
| L-Arabinose | Sugar Reduction / Metabolic Health | Development/Commercial |
| Vanillin (Evolva® V) | Natural Flavoring | Commercial |
| Saffron (Crocins) | Natural Colorant / Health Ingredient | Research |
| Santalin | Natural Red Colorant | Research |
| Pterostilbene | Health & Wellness Ingredient | Research |
Leadership Team at Evolva Holding SA
JK
Jens Kengelbach
Chief Financial Officer (CFO)
MF
Michael F. Buschle
Chief Technology Officer (CTO)
NG
Nathalie Giger
Head of Human Resources
BK
Beat Krähenmann
Head of Operations & Supply Chain
DS
Dr. Sonja Kessler
Head of Legal & Compliance
MO
Michael O. Sailer
Chairman of the Board
DS
Dr. Stephan Kutzer
Board Member
DC
Dr. Caroline Wyss
Board Member
DJ
Dr. Jürgen Eck
Board Member
RD
Roland Decorvet
Board Member